These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30550845)

  • 1. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
    Li Y; Wang N; Jiang Y
    Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
    Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
    Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
    Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
    Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
    Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
    J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
    Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
    Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
    Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
    Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
    Kim SJ; Lee SM
    Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
    Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
    Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
    Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
    Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.
    Lv H; Fan X; Wang L; Feng H; Ci X
    Int J Biol Macromol; 2018 Nov; 119():240-248. PubMed ID: 30031824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
    Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
    Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
    Zhu Y; Chen X; Rao X; Zheng C; Peng X
    Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.